Atria Investments’s Stemline Therapeutics, Inc. STML Stock Holding History

Atria Investments’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,262	Closed	-$98K	–	816
2020 Q1	$98K	Buy	20,262 +5,565	+38%	+$36.1K	0.01%	561
2019 Q4	$156K	Buy	+14,697	New	+$146K	﹤0.01%	1170
2019 Q2	–	Sell	-10,827	Closed	-$139K	–	1114
2019 Q1	$139K	Buy	10,827 +746	+7%	+$8.43K	0.01%	896
2018 Q4	$96K	Buy	+10,081	New	+$131K	﹤0.01%	860

Atria Investments's STML Position: Q2 2020 in Review

Atria Investments sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 20,262 shares — an estimated $98K sold.

Atria Investments first reported a position in STML in Q4 2018 and held it in 4 quarters. The position peaked at $156K in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Atria Investments reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Atria Investments sold 20,262 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $98K.
Atria Investments first reported a position in Stemline Therapeutics, Inc. in Q4 2018 and held it in 4 quarters.
Atria Investments's Stemline Therapeutics, Inc. position peaked at $156K in Q4 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.